TNFRSF13C and precursor B-cell acute lymphoblastic leukemia: We also characterized promising, clinically explored targets that are tested in blood cancers derived from B cells at various stages of development and maturation, including BAFF-R (B-ALL), CD37 (CLL, B cell lymphoma), and GPRC5D (MM).